The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
TLR signaling in mast cells: common and unique features
Open accessAbstract
In addition to the well known role of mast cells in immunity to multi-cellular parasites and in the pathogenesis of allergy and asthma, the importance of mast cells in the immune defense against bacteria and viruses is increasingly being recognized. Their location in the skin, gut, and airways puts mast cells in an ideal location to encounter and respond to pathogens, and in order to perform this function, these cells express a variety of pattern recognition receptors, including Toll-like receptors (TLRs). Mast cells respond to TLR ligands by secreting cytokines, chemokines, and lipid mediators, and some studies have found that TLR ligands can also cause degranulation, although this finding is contentious. In addition, stimulation via TLR ligands can synergize with signaling via the FcεRI, potentially enhancing the response of the cells to antigen in vivo. A great deal is now known about TLR signaling pathways. Some features of these pathways are cell type-specific, however, and work is under way to fully elucidate the TLR signaling cascades in the mast cell. Already, some interesting differences have been identified. This review aims to address what is known about the responses of mast cells to TLR ligands and the signaling pathways involved. Given the location of mast cells at sites exposed to the environment, the response of these cells to TLR ligands must be carefully regulated. The known mechanisms behind this regulation are also reviewed here.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
LPS/TLR4 signal transduction pathway
Lu, Y.-C., Yeh, W.-C., & Ohashi, P. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.01.006 · Cited by 3,301
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S., & Underhill, D. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021787 · Cited by 1,643
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
Kagan, J. C., Su, T., Horng, T., Chow, A., Akira, S., & Medzhitov, R. (2008) · Nature Immunology · doi:10.1038/ni1569 · Cited by 1,253
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Zanoni, I., Ostuni, R., Marek, L. R., Barresi, S., Barbalat, R., Barton, G. M., Granucci, F., & Kagan, J. C. (2011) · Cell · doi:10.1016/j.cell.2011.09.051 · Cited by 997
Integrated signalling pathways for mast-cell activation
Gilfillan, A. M., & Tkaczyk, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1782 · Cited by 950
Mast-cell responses to pathogens
Marshall, J. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1460 · Cited by 861
Mast cell-orchestrated immunity to pathogens
Abraham, S. N., & St. John, A. L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2782 · Cited by 837
Yano, H., Nakanishi, S., Kimura, K., Hanai, N., Saitoh, Y., Fukui, Y., Nonomura, Y., & Matsuda, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74466-4 · Cited by 725
Ahmad-Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · Cited by 717
Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells
Matsumoto, M., Funami, K., Tanabe, M., Oshiumi, H., Shingai, M., Seto, Y., Yamamoto, A., & Seya, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3154 · Cited by 707
Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells
Re, F., & Strominger, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105927200 · Cited by 691
CD14 is required for MyD88-independent LPS signaling
Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M., Kalis, C., Keck, S., Galanos, C., et al. (2005) · Nature Immunology · doi:10.1038/ni1207 · Cited by 670
Mansell, A., Smith, R., Doyle, S. L., Gray, P., Fenner, J. E., Crack, P. J., Nicholson, S. E., Hilton, D. J., O'Neill, L. A. J., & Hertzog, P. J. (2006) · Nature Immunology · doi:10.1038/ni1299 · Cited by 514
Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity
Supajatura, V., Ushio, H., Nakao, A., Akira, S., Okumura, K., Ra, C., & Ogawa, H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14704 · Cited by 491
Accessory molecules for Toll-like receptors and their function
Lee, C. C., Avalos, A. M., & Ploegh, H. L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3151 · Cited by 439
Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity
Supajatura, V., Ushio, H., Nakao, A., Akira, S., Okumura, K., Ra, C., & Ogawa, H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214704 · Cited by 403
Supajatura, V., Ushio, H., Nakao, A., Okumura, K., Ra, C., & Ogawa, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2250 · Cited by 370
Kulka, M., Alexopoulou, L., Flavell, R. A., & Metcalfe, D. D. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.049 · Cited by 351
McCurdy, J. D., Olynych, T. J., Maher, L. H., & Marshall, J. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1625 · Cited by 349
Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12
Hamerman, J. A., Tchao, N. K., Lowell, C. A., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1204 · Cited by 318
Huber, M., Helgason, C. D., Damen, J. E., Liu, L., Humphries, R. K., & Krystal, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11330 · Cited by 316
LPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance
Sly, L. M., Rauh, M. J., Kalesnikoff, J., Song, C. H., & Krystal, G. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.010 · Cited by 306
Jefferies, C. A., Doyle, S., Brunner, C., Dunne, A., Brint, E., Wietek, C., Walch, E., Wirth, T., & O'Neill, L. A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301484200 · Cited by 292
Toll‐like receptor 2 (TLR2) and TLR4 differentially activate human mast cells
Varadaradjalou, S., Féger, F., Thieblemont, N., Hamouda, N. B., Pleau, J., Dy, M., & Arock, M. (2003) · European Journal of Immunology · doi:10.1002/eji.200323830 · Cited by 291
Beyond pattern recognition: five immune checkpoints for scaling the microbial threat
Blander, J. M., & Sander, L. E. (2012) · Nature Reviews Immunology · doi:10.1038/nri3167 · Cited by 290
Pattern recognition: recent insights from Dectin-1
Reid, D. M., Gow, N. A., & Brown, G. D. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.003 · Cited by 289
Matsushima, H., Yamada, N., Matsue, H., & Shimada, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.531 · Cited by 270
Martin, M., Schifferle, R. E., Cuesta, N., Vogel, S. N., Katz, J., & Michalek, S. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.717 · Cited by 257
Pathogen recognition by innate immunity and its signaling
AKIRA, S. (2009) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.85.143 · Cited by 240
Toll-like receptor 4-mediated activation of murine mast cells
McCurdy, J. D., Lin, T.-J., & Marshall, J. S. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.6.977 · Cited by 209
Yi, A.-K., Yoon, J.-G., Yeo, S.-J., Hong, S.-C., English, B. K., & Krieg, A. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4711 · Cited by 196
Wang, Z.-M., Liu, C., & Dziarski, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909168199 · Cited by 190
Role of Phosphoinositide 3-Kinase in Innate Immunity
Hazeki, K., Nigorikawa, K., & Hazeki, O. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1617 · Cited by 188
Qiao, H., Andrade, M. V., Lisboa, F. A., Morgan, K., & Beaven, M. A. (2006) · Blood · doi:10.1182/blood-2005-06-2271 · Cited by 185
A Novel TLR4-Mediated Signaling Pathway Leading to IL-6 Responses in Human Bladder Epithelial Cells
Song, J., Duncan, M. J., Li, G., Chan, C., Grady, R., Stapleton, A., & Abraham, S. N. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030060 · Cited by 177
R‐form LPS, the master key to the activation ofTLR4/MD‐2‐positive cells
Huber, M., Kalis, C., Keck, S., Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Beutler, B., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200535593 · Cited by 169
Masuda, A., Yoshikai, Y., Aiba, K., & Matsuguchi, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3801 · Cited by 169
Okumura, S., Kashiwakura, J., Tomita, H., Matsumoto, K., Nakajima, T., Saito, H., & Okayama, Y. (2003) · Blood · doi:10.1182/blood-2002-12-3929 · Cited by 168
Kawagoe, T., Takeuchi, O., Takabatake, Y., Kato, H., Isaka, Y., Tsujimura, T., & Akira, S. (2009) · Nature Immunology · doi:10.1038/ni.1771 · Cited by 168
Horwood, N. J., Mahon, T., McDaid, J., Campbell, J., Mano, H., Brennan, F. M., Webster, D., & Foxwell, B. M. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021845 · Cited by 163
Kalesnikoff, J., Baur, N., Leitges, M., Hughes, M. R., Damen, J. E., Huber, M., & Krystal, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4737 · Cited by 130
Olynych, T., Jakeman, D. L., & Marshall, J. S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.06.008 · Cited by 121
Kawakami, T., & Kitaura, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4167 · Cited by 120
The MYD88-Independent Pathway Is Not Mobilized in Human Neutrophils Stimulated via TLR4
Tamassia, N., Moigne, V. L., Calzetti, F., Donini, M., Gasperini, S., Ear, T., Cloutier, A., Martínez, F. O., Fabbri, M., Locati, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7344 · Cited by 110
Mrabet‐Dahbi, S., Metz, M., Dudeck, A., Zuberbier, T., & Maurer, M. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00878.x · Cited by 98
Bruton’s Tyrosine Kinase Is Required for TLR-Induced IL-10 Production
Schmidt, N. W., Thieu, V. T., Mann, B. A., Ahyi, A.-N. N., & Kaplan, M. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7203 · Cited by 91
Kikawada, E., Bonventre, J. V., & Arm, J. P. (2007) · Blood · doi:10.1182/blood-2006-10-052258 · Cited by 79
Dietrich, N. L., Rohde, M., Geffers, R., Kröger, A., Häuser, H., Weiß, S., & Gekara, N. O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912551107 · Cited by 78
Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan
Ikeda, T., & Funaba, M. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00031-2 · Cited by 75
Lipoteichoic acid downregulates FcεRI expression on human mast cells through Toll-like receptor 2
Yoshioka, M., Fukuishi, N., Iriguchi, S., Ohsaki, K., Yamanobe, H., Inukai, A., Kurihara, D., Imajo, N., Yasui, Y., Matsui, N., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.027 · Cited by 74
Protein Kinase D1 Is Essential for MyD88-Dependent TLR Signaling Pathway
Park, J. J., Kim, Y., & Yi, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804239 · Cited by 59
Kirshenbaum, A. S., Swindle, E. J., Kulka, M., Wu, Y., & Metcalfe, D. D. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-45 · Cited by 57
Li, G., Domenico, J. M., Jia, Y., Lucas, J. J., & Gelfand, E. W. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000218115 · Cited by 55
Hochdörfer, T., Kuhny, M., Zorn, C. N., Hendriks, R. W., Vanhaesebroeck, B., Bohnacker, T., Krystal, G., & Huber, M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.01.012 · Cited by 54
Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes
de Diego, R. P., López‐Granados, E., Pozo, M., Rodrı́guez, C., Sabina, P., Ferreira, A., Fontan, G., García-Rodríguez, M. C., & Alemany, S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.037 · Cited by 52
Absence of TRIF Signaling in Lipopolysaccharide-Stimulated Murine Mast Cells
Keck, S., Müller, I., Fejér, G., Savic, I., Tchaptchet, S., Nielsen, P. J., Galanos, C., Huber, M., & Freudenberg, M. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000458 · Cited by 41
Robyn, J. A., & Metcalfe, D. D. (2006) · Advances in immunology · doi:10.1016/s0065-2776(05)89005-4 · Cited by 39
Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells
Zorn, C. N., Keck, S., Hendriks, R. W., Leitges, M., Freudenberg, M. A., & Huber, M. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.09.010 · Cited by 38
Stimulation of mast cells via FcɛR1 and TLR2: The type of ligand determines the outcome
Fehrenbach, K., Port, F., Grochowy, G., Kalis, C., Bessler, W. G., Galanos, C., Krystal, G., Freudenberg, M. A., & Huber, M. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.011 · Cited by 36
Signaling through Toll‐like receptor 4 and mast cell‐dependent innate immunity responses
Martín‐Ávila, A., & González‐Espinosa, C. (2011) · IUBMB Life · doi:10.1002/iub.555 · Cited by 33
Saturnino, S. F., Prado, R. O., Cunha-Melo, J. R., & de Andrade, M. V. M. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-240 · Cited by 29
Medina‐Tamayo, J., Ibarra-Sánchez, A., Padilla-Trejo, A., & González‐Espinosa, C. (2010) · Inflammation Research · doi:10.1007/s00011-010-0230-4 · Cited by 28
Haidl, I. D., McAlpine, S. M., & Marshall, J. S. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000321109 · Cited by 26
Murphy, T. R., Legere, H. J., & Katz, H. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7876 · Cited by 25
MD-2 is required for the full responsiveness of mast cells to LPS but not to PGN
Ushio, H., Nakao, A., Supajatura, V., Miyake, K., Okumura, K., & Ogawa, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.108 · Cited by 19
Smrž, D., Iwaki, S., McVicar, D. W., Metcalfe, D. D., & Gilfillan, A. M. (2010) · European Journal of Immunology · doi:10.1002/eji.201040573 · Cited by 18
Monomeric IgE and lipopolysaccharide synergistically prevent mast-cell apoptosis
Jayawardana, S. T. M., Ushio, H., Niyonsaba, F., Gondokaryono, S. P., Takenaka, H., Ikeda, S., Okumura, K., & Ogawa, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.136 · Cited by 11
Cited by
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Crop immunity against viruses: outcomes and future challenges
Nicaise, V. (2014) · Frontiers in Plant Science · doi:10.3389/fpls.2014.00660 · Cited by 385
Innate cell communication kick-starts pathogen-specific immunity
Rivera, A., Siracusa, M. C., Yap, G. S., & Gause, W. C. (2016) · Nature Immunology · doi:10.1038/ni.3375 · Cited by 259
New perspectives on the origins and heterogeneity of mast cells
St. John, A. L., Rathore, A. P. S., & Ginhoux, F. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00731-2 · Cited by 126
Selected recent advances in understanding the role of human mast cells in health and disease
Levi-Schaffer, F., Gibbs, B. F., Hallgren, J., Pucillo, C., Redegeld, F., Siebenhaar, F., Vitte, J., Mezouar, S., Michel, M., Puzzovio, P. G., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.030 · Cited by 51
Metadata
- Authors
- Sandig, H., & Bulfone-Paus, S.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 185-185
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2026579891
- Cited by
- 268
- References
- 69
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.